What are the opening hours?

Monday 8am - 5pm Tuesday 8am - 5pm Wednesday 8am - 5pm Thursday 8am - 5pm Friday 8am - 5pm

https://www.facebook.com/480534312388839/

Texas Retina Associates

Home
United States
Athens, TX
Texas Retina Associates

Call Directions

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Texas Retina Associates, Ophthalmologist, 405 E. Clinton Avenue, Suite A, Athens, TX.

10/16/2026

We love ending the week on a high note, and today we’re thankful for this feedback about Dr. Wang!

A part of Texas Retina for 24 years now, he treats a full range of retina conditions and sub-specializes in uveitis, a rare and serious inflammatory eye condition.

Dr. Wang currently cares for patients in our Dallas Main, Dallas North, Plano and Sherman offices, and also serves as our Director of Clinical Research for Plano.

Learn more about Dr. Wang: https://www.texasretina.com/our-physicians/robert-c-wang-md

10/14/2026

Did you know that wearing protective eyewear could prevent 90% of eye injuries?

October is Eye Injury Prevention Month, and the temperatures in Texas are finally starting to cool down a bit. Whether you are tackling a DIY home improvement project or enjoying some fall fun in the sun, Texas Retina reminds you to protect your eyes from both injury and sun damage.

Learn four steps you can take in our latest blog: https://www.texasretina.com/2026/09/30/eye-injury-prevention-month-four-tips-to-protect-your-eyes

10/08/2026

“What makes the ARCHER trials exciting is that vonaprument is being evaluated with the potential to directly preserve and protect vision, rather than simply slowing the growth of lesions. This could be a significant step forward in our treatment approach to geographic atrophy (GA) secondary to dry AMD, and we look forward to learning more through the Phase 3 study.”
– Ashkan Abbey, MD, Director of Clinical Research for Dallas, Texas Retina

Dr. Abbey recently presented baseline characteristics from the Phase 3 ARCHER II clinical trial at The Retina Society’s 59th Annual Scientific Meeting in Los Angeles.

The global ARCHER II study is evaluating vonaprument (ANX007), an investigational intravitreal C1q inhibitor. The Phase 3 trial is now fully enrolled with 659 patients, and our team at Texas Retina had the privilege of enrolling a large number of patients in the study.

Learn more and access a video of Dr. Abbey highlighting his presentation: https://www.texasretina.com/2026/10/07/dr-abbey-presents-archer-ii-clinical-trial-data-at-the-retina-society-annual-scientific-meeting

10/06/2026

Texas Retina has launched a new Careers page to make it easier to learn about current openings within our organization.

For more than six decades, Texas Retina has brought together people who care deeply about helping patients protect their vision and live their lives to the fullest. Our team includes physicians, clinical staff and the many people who support our practice behind the scenes. Each plays an important role in providing patient care and helping Texas Retina continue to grow.

Learn more about our current career opportunities: https://www.texasretina.com/careers

10/01/2026

Congratulations to Texas Retina’s Dr. Ashkan Abbey on receiving the 2026 Achievement Award from the American Academy of Ophthalmology!

This prestigious recognition celebrates Dr. Abbey’s 15 years of contributions to the AAO through education, scientific programming and advancement of the field of ophthalmology. We’re proud to celebrate his continued dedication to advancing retinal care and ophthalmic education.

Read more about Dr. Abbey and this well-deserved honor: https://www.texasretina.com/2026/09/30/dr-abbey-receives-2026-achievement-award-from-the-american-academy-of-ophthalmology

09/29/2026

Today we’re grateful for this recent feedback about Dr. Michel J. Shami, who cares for patients at Texas Retina’s Lubbock office.

A part of Texas Retina’s medical team since 2001, Dr. Shami is also an active researcher with the DRCR Retina Network, a U.S.-based, federally funded network of more than 400 physicians across the United States and Canada. Together, they conduct collaborative clinical research focused on advancing the prevention, diagnosis and treatment of retinal diseases.

For Dr. Shami, the greatest rewards of his work are earning the trust of his patients, meeting their expectations and helping restore sight.

Learn more about Dr. Shami: https://www.texasretina.com/our-physicians/michel-j-shami-md

09/24/2026

“The most compelling finding of the SALWEEN study is that faricimab monotherapy produced a very high degree of control of the underlying polypoidal lesions and maintained that control despite exceptionally long treatment intervals.”
– Ashkan Abbey, MD, Texas Retina

Dr. Abbey shared his perspective on the Phase 3b/4 SALWEEN study evaluating VABYSMO® (faricimab-svoa) for the treatment of polypoidal choroidal vasculopathy (PCV) in the current issue of Ocular Surgery News on Healio. PCV is an aggressive subtype of neovascular (wet) age-related macular degeneration (AMD).

Learn more about the SALWEEN study findings: https://www.texasretina.com/2026/09/23/dr-abbey-discusses-the-use-of-vabysmo-for-polypoidal-choroidal-vasculopathy

09/22/2026

When a macular hole doesn’t close after surgery, treatment can be especially challenging. Texas Retina’s Dr. Rene Choi has developed a new surgical technique designed to address these complex cases.

Recently published in Retinal Cases & Brief Reports, Dr. Choi’s case report describes how he uses small grafts of retinal tissue to help close a persistent macular hole. In the reported case, the patient’s best-corrected visual acuity improved from 20/200 to 20/50 five months after surgery.

Dr. Choi co-authored the report with Anirudh Gadicherla and Amirmohammad Shafiee, two medical students he mentors at TCU’s Anne Burnett School of Medicine.

Read the full story to learn more about this innovative approach and Dr. Choi’s work advancing surgical care for complex retinal conditions: https://www.texasretina.com/2026/09/22/dr-choi-develops-new-surgical-technique-for-macular-holes-that-fail-to-close-after-initial-surgery

09/17/2026

Texas Retina physicians work hard to earn the trust of our patients, and it is something we don’t take for granted. That is why we love receiving feedback like this about Dr. Laura and her team.

She joined Texas Retina four years ago after completing her vitreoretinal surgery fellowship and ophthalmology residency at Bascom Palmer Eye Institute at the University of Miami, one of the top-rated eye hospitals in the country.

Dr. Laura currently cares for patients in Texas Retina’s Dallas Main, Rockwall and Denton offices and believes establishing compassionate and meaningful relationships with her patients is crucial.

You can learn more about Dr. Laura here: https://www.texasretina.com/our-physicians/diana-m-laura-md

09/15/2026

We’re proud to share that the Texas Retina Dallas research team has been recognized as the highest-enrolling site globally for Part I of the DFI18231 study evaluating SAR446597 for geographic atrophy secondary to age-related macular degeneration (AMD).

Part II of the study opened in August, and both Texas Retina’s Dallas and Fort Worth research teams are participating.

Learn more: https://www.texasretina.com/2026/09/15/texas-retina-dallas-research-team-recognized-for-highest-site-enrollment-globally-in-geographic-atrophy-clinical-trial

Address

405 E. Clinton Avenue, Suite A
Athens, TX
75751

Opening Hours

Monday	8am - 5pm
Tuesday	8am - 5pm
Wednesday	8am - 5pm
Thursday	8am - 5pm
Friday	8am - 5pm

Telephone

+18006956941

Website

facebook.com

Alerts

Be the first to know and let us send you an email when Texas Retina Associates posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Psych Dimensions

Want your practice to be the top-listed clinic in Athens?